Elevated Homocysteine Level and Brain Atrophy Changes as Markers to Screen the Alzheimer Disease: Case Series
Alzheimer disease (AD) is the most common cause of dementia worldwide. Its clinical manifestations include a progressive loss of memory and other cognitive domains, as well as brain atrophy. An elevated homocysteine level (>15 µmol/L), known as hyperhomocysteinemia, is also an attributing risk fa...
Κύριοι συγγραφείς: | Ram Prakash Sah, C. S. Vidya, Pratibha Pereira, Shubha Jayaram, Anshu Kumar Yadav, P. Sujatha |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
Korea Geriatrics Society
2024-03-01
|
Σειρά: | Annals of Geriatric Medicine and Research |
Θέματα: | |
Διαθέσιμο Online: | http://www.e-agmr.org/upload/pdf/agmr-23-0135.pdf |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Serum Levels of Homocysteine, Vitamin B12, and Folic Acid in Patients with Alzheimer’s Disease
ανά: Fariba Karimi, κ.ά.
Έκδοση: (2009-06-01) -
Association of Elevated Plasma Total Homocysteine With Dementia With Lewy Bodies: A Case-Control Study
ανά: Guili Zhang, κ.ά.
Έκδοση: (2021-10-01) -
Maternal and Cord Blood Vitamin B12, Folate and Homocysteine Levels
ανά: Selime Özen Bölük, κ.ά.
Έκδοση: (2022-06-01) -
Homocysteine and methylmalonic acid in Phenylketonuria patients
ανά: Giovana Regina Weber Hoss, κ.ά.
Έκδοση: (2024-04-01) -
The evaluation of serum homocysteine, folic acid, and vitamin B12 in patients complicated with preeclampsia
ανά: Nahid Shahbazian, κ.ά.
Έκδοση: (2016-10-01)